Home
About Synergy
Mission & Values
Management Team
Board of Directors
Clinical Advisory Board
Science & Technology
Discoveries
Diseases
Posters & Publications
Pipeline
Plecanatide
SP-333
Clinical Trials
Plecanatide for CIC
Plecanatide for IBS-C
SP-333 For UC
Development Team
News & Media
Press Releases
Webcasts
Presentations
Fact Sheets
Video Gallery
Investor Relations
Overview
News / Events
Press Releases
Webcasts
Presentations
IR Calendar
Email Alerts
Company Information
Profile
Management Team
FAQ
IR Contacts
Financial Information
Financials
Annual Reports
Proxy
Stock Information
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Section 16 Filings
Corporate Governance
Board of Directors
Board Committees
Governance Documents
Contact Us
Careers
For Patients
Home
About Synergy
Mission & Values
Management Team
Board of Directors
Clinical Advisory Board
Science & Technology
Discoveries
Diseases
Posters & Publications
Pipeline
Plecanatide
SP-333
Clinical Trials
Plecanatide for CIC
Plecanatide for IBS-C
SP-333 For UC
Development Team
News & Media
Press Releases
Webcasts
Presentations
Fact Sheets
Video Gallery
Investor Relations
Overview
News / Events
Press Releases
Webcasts
Presentations
IR Calendar
Email Alerts
Company Information
Profile
Management Team
FAQ
IR Contacts
Financial Information
Financials
Annual Reports
Proxy
Stock Information
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Section 16 Filings
Corporate Governance
Board of Directors
Board Committees
Governance Documents
Contact Us
Careers
For Patients
Our Focus is on
Gastrointestinal Disease
Creating
Proprietary
Analogues
of a Natural
GI Hormone
Our Proprietary
Compounds Activate GI Mucosa
to Regulate the Bowel
Now Enrolling
CIBS STUDY
Plecanatide
Novel approach for GI disease
Learn More
Synergy
Pioneering GI research & development
Learn more
Press Releases
Jun 3, 2013
Synergy Pharmaceuticals Announces Change in Presentation Time at Jefferies 2013 Global Healthcare Conference
May 31, 2013
Synergy Pharmaceuticals to Present at Jefferies 2013 Global Healthcare Conference
May 30, 2013
Synergy Pharmaceuticals Added to the MSCI Global Small Cap Indices
More news
